newsfilter
← Latest News
Business Wire·

Alnylam Issues 2025 Corporate Responsibility Report

– Published Scope 1 and Scope 2 Greenhouse Gas (GHG) Emissions Reduction Framework through 2030 – – Expanded Global Patient Access and Support – Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), the leading RNAi